BRIEF-Valeant Pharmaceuticals receives notice of default from bondholders due to delayed 10-K Filing

Tue Apr 12, 2016 5:08pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 12 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant pharmaceuticals receives notice of default from bondholders due to delayed 10-k filing

* On schedule to file its 10-k on or before april 29, 2016

* Says company has until june 11, 2016 to cure default by filing 10-k

* Notice of default does not result in acceleration of any of company's indebtedness

* Received a notice of default from holders of its 5.5% notes due 2023 as a result of delay in company filing its form 10-k

* Says "company is on schedule to file its 10-k on or before april 29, 2016" Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)